The 17th Annual Market Access USA 2019 covers topics such as:
- The value-based blueprint
- Speed up negotiations and engage payer needs with the essential framework for value-based contracts
- Collaborate to innovate
- Engage payers, providers and patients to develop a system that benefits all
- More evidence = earlier access
- How RWE can unlock phase 2 access
- Affordability first
- Develop innovative payment solutions that provide affordable access to life-changing treatments
The 17th Annual Market Access USA 2019 brings together senior attendees with responsibilities in market access from the pharma industry.
